Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 317 - Sulfones; Sulfoxides
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
10/2005
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005CN1684943A Process for producing high-purity 4, 4'-dihydroxydiphenyl sulfone
10/19/2005CN1684678A Thiomolybdate analogues and uses thereof
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/18/2005US6956091 Organic anti-reflective polymer and preparation thereof
10/18/2005US6955888 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/13/2005WO2005095335A1 Ylide compounds, process for production of the same, and use thereof as herbicide and intermediates of drugs
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005095307A1 Method for forming a carbon-carbon bond comprising an arenodiazo ether reaction
10/13/2005US20050228040 Bicyclic aromatic sulfinyl derivatives
10/13/2005US20050227995 Phenyl sulfoxides and phenyl sulfones
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005DE10392134T5 Azaphenylalaninderivate Azaphenylalaninderivate
10/12/2005EP1583739A1 Method for preparing methyl 2-diphenylmethylsulfinylacetate
10/12/2005EP1583738A1 Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia
10/12/2005CN1681776A Amino alcohol derivative, addition salt thereof, and immunosuppressant
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1680308A New 3-aryl-2-hydroxypropionic acid derivative I
10/11/2005US6953812 Carboxy and amide containing compound suitable for treatment and/or prevention of diseases wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, diabetes, disorders of the lipid metabolism, such as dyslipidemia
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/06/2005WO2005092997A1 Surface treating agent, fluorine-containing monomer and fluorine-containing polymer
10/06/2005WO2005092937A1 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
10/06/2005WO2005092904A1 Novel compounds for modulating cell proliferation
10/06/2005WO2005092846A1 Process for purifying mesotrione
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005046599A3 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
10/06/2005US20050222456 Synthesis of cyclohexanone derivatives
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222257 Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
10/06/2005US20050222253 Anti-cancer nitro- and thia-fatty acids
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005CA2560584A1 Novel compounds for modulating cell proliferation
10/06/2005CA2560392A1 Surface treating agent, fluorine-containing monomer and fluorine-containing polymer
10/06/2005CA2560388A1 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
10/06/2005CA2557794A1 Opioid receptor antagonists
10/05/2005EP1581474A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/05/2005CN1221504C Perfluoroisopropylbenzene derivatives
10/04/2005US6951945 Heteroaromatic glucokinase activators
09/2005
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090296A2 N-substituted benzene sulfonamides
09/29/2005WO2005089511A2 Novel pharmaceutical forms, and methods of making and using the same
09/29/2005WO2005089269A2 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050215435 Phenylalanine derivatives as herbicides
09/29/2005US20050214853 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2559047A1 N-substituted benzene sulfonamides
09/28/2005EP1474381B1 Phenylalanine derivatives as herbicides
09/28/2005EP1341534A4 Compounds having fungicidal activity and processes to make and use same
09/28/2005EP1242397B1 Trans olefinic glucokinase activators
09/28/2005EP1093453B1 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/28/2005CN1675177A Modafinil polymorphic forms
09/28/2005CN1675145A Method of deuterating aromatic ring
09/27/2005US6949678 For resist applications; thermostability, storage stability
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/27/2005CA2122346C Bistriazenes as chemotherapeutic agents
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087700A2 Bisphenyl compounds useful as vitamin d3 receptor agonists
09/22/2005US20050209333 Malonamic acids and derivatives thereof as thyroid receptor ligands
09/22/2005US20050209320 Compounds comprise an androgen receptor (AR) binding moiety which selectively targets the compounds to AR-expressing cancer cells, and a cytotoxic alkylating moiety, such as a nitrogen mustard moiety; (2R)-2-hydroxy-3-[(4-hydroxyphenyl)thio]-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
09/22/2005DE102004010950A1 Verfahren zur Aufarbeitung von ß-Sulfatoethylsulfonylanilin-2-sulfonsäure A process for the work-up of beta-sulfatoethylsulfonylaniline-2-sulfonic acid
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/21/2005EP1575915A1 Modafinil polymorphic forms
09/21/2005EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists
09/21/2005CN1671655A Novel phthalamide derivatives
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/20/2005US6946489 Substituted biphenyl derivatives
09/20/2005US6946471 2-(2,6-Dichlorophenyl)-Diarylimidazoles
09/15/2005WO2005085190A1 METHOD FOR PROCESSING ss-SULPHATOETHYLSULPHONYLANILINE-2-SULPHONIC ACID
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/14/2005EP1572635A1 Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
09/14/2005CN1218941C Process for preparing ethyl-sulfonylpiperidine derivatives
09/13/2005CA2058553C Preparation of e-oxime ethers of phenylglyoxylic esters
09/07/2005EP1571141A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/07/2005EP1571140A1 C-substituted cyclohexylmethylamine derivatives
09/07/2005EP1569896A1 Tetrahydro-naphthalene derivatives
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/06/2005US6939986 From 1,2-epoxides; useful as inhibitors of viral or bacterial neuraminidases
09/06/2005US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine,
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/01/2005WO2005080309A1 Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid
09/01/2005WO2005079863A1 Contrast medium for thrombus formation
09/01/2005WO2005079700A2 Methods using fluorosulfones for extinguishing and preventing fire,
09/01/2005WO2005079270A2 2-substituted and 4-substituted aryl nitrone compouds
09/01/2005WO2005063665B1 Propofol analogs, process for their preparation, and methods of use
09/01/2005WO2005051899A3 Monomer compound, graft copolymer compound, production method thereof, polymer electrolyte membrane, and fuel cell
09/01/2005US20050192346 Process for making nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
09/01/2005US20050192336 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050191567 Oxime ester photoinitiators
09/01/2005CA2558064A1 Contrast medium for thrombus formation
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 159